Apollomics
APLM • NASDAQ
Apollomics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Hung-Wen Chen, with a market cap of $31.9M.
Market Cap$31.9M
Employees45.0
CEOHung-Wen Chen
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsApr 21, 2026 · In 1 weekFY 2025
Financials
Apollomics FAQ
Common questions about Apollomics
Apollomics is scheduled to report earnings for FY 2025 on April 21, 2026.
Apollomics has approximately 45 employees.